Stelux Holdings International Limited (HKG:0084)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	73	77	85	70	64	92
Market Cap Growth	-9.48%	-9.48%	20.90%	9.84%	-30.68%	3.53%
Enterprise Value	311	383	446	354	529	725
Last Close Price	0.07	0.07	0.08	0.07	0.06	0.09
PE Ratio	-	-	0.18	1.38	-	-
Forward PE	-	5.79	5.79	5.79	5.79	5.79
PS Ratio	0.12	0.13	0.11	0.09	0.09	0.13
PB Ratio	0.08	0.08	0.09	0.16	0.17	0.19
P/TBV Ratio	0.08	0.09	0.10	0.19	0.20	0.21
P/FCF Ratio	4.37	4.63	-	1.31	0.77	0.51
P/OCF Ratio	2.93	3.10	-	1.15	0.69	0.50
PEG Ratio	-	0.29	0.29	0.29	0.29	0.29
EV/Sales Ratio	0.51	0.62	0.58	0.44	0.76	1.03
EV/EBITDA Ratio	-	-	30.03	-	-	-
EV/FCF Ratio	18.76	23.06	-	6.61	6.37	4.00
Debt / Equity Ratio	0.36	0.36	0.38	1.01	1.47	1.35
Debt / EBITDA Ratio	-	-	4.51	12.91	35.57	-
Debt / FCF Ratio	19.68	19.68	-	8.13	6.80	3.69
Asset Turnover	0.43	0.43	0.62	0.72	0.55	0.46
Inventory Turnover	1.42	1.42	1.61	1.82	1.42	1.27
Quick Ratio	0.45	0.45	0.44	0.35	0.34	0.41
Current Ratio	1.04	1.04	1.06	0.74	0.75	0.76
Return on Equity (ROE)	-11.66%	-11.66%	70.52%	12.54%	-24.21%	-15.82%
Return on Assets (ROA)	-3.38%	-3.38%	-0.36%	-2.27%	-4.17%	-6.80%
Return on Capital (ROIC)	-3.85%	-3.85%	-0.42%	-2.80%	-5.01%	-7.87%
Earnings Yield	-147.41%	-139.44%	558.20%	72.45%	-167.18%	-88.92%
FCF Yield	22.86%	21.62%	-36.59%	76.46%	130.20%	196.75%
Buyback Yield / Dilution	0.53%	0.53%	-	-	-	-
Total Shareholder Return	-	0.53%	-	-	-	-

Updated Dec 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.